- AdventHealth
One year ago (March 2022), AdventHealth opened its first Post-COVID Clinic (PCC) to address clinical care for patients with long COVID and support COVID-related research.
Richard E. Pratley, M.D., medical director of the AdventHealth Diabetes Institute and senior scientist in diabetes research at the AdventHealth Translational Research Institute, and Dwayne Gordon, M.D., internal medicine physician with the AdventHealth Medical Group and lead physician at the PCC, recently appeared on the American Hospital Association’s Advancing Health podcast to discuss the improvements in patient outcomes and why investing in research and sharing collective experiences is key to minimizing COVID’s hold on the global community.
The Big Picture:
As the health care community evolves from pandemic to endemic, many hospitals are realizing the need for multidisciplinary clinics, like the AdventHealth model.
Successful Patient Outcomes:
Kathy Fennimore, 62, was the first patient to “graduate” from the clinic after six months of treatments and various therapies. She came into the clinic dependent on supplemental oxygen 24/7. The virus had exacerbated the pulmonary fibrosis, hypertension and autoimmune disease she’d been dealing with most of her life. She could barely walk 5-10 feet and couldn’t finish a six-minute walking test. Thanks to the care and treatment protocols at the PCC, she's now off oxygen, back at work, and is walking two to three miles a day.
Why we should pursue long COVID clinics...
Why research matters:
Scientists understand what COVID is and how it affects people but are still learning why symptoms occur and vary from patient-to-patient. Investigating the “why” through research is the path to determining better treatments.
Pre-pandemic, researchers at the AdventHealth Translational Research Institute were leading a multitude of research studies in metabolism, diabetes, and more – all of which had to essentially shut down (with the exception of very critical trials) in light of the clinical response to the pandemic.
Now, AdventHealth has entered a new phase where the focus is on better understanding long COVID.
Why investing in COVID research is key...
About the PCC:
The PCC currently has limited capacity, but a phased expansion is planned.
If you are a physician and have patients that may be a candidate for the PCC, email CFD.PostCOVIDClinic@adventhealth.com the patient’s name and contact information, as well as your name and contact information, and the PCC will follow-up to determine if the patient is qualified.
If you are a patient requesting more information or would like to see if you qualify for the PCC, please email CFD.PostCOVIDClinic@adventhealth.com. Please note a referral is required from your primary care physician.
To listen to the full AHA podcast featuring Dr. Pratley and Dr. Gordon, click here.
In addition to the PCC in Central Florida, AdventHealth has another long COVID clinic on Florida’s west coast at AdventHealth Tampa which focuses on pulmonary issues.
Recent News
Kidney-tumor patients have an innovative new treatment option, first performed recently by a surgical team at AdventHealth Celebration.
Test Apple Podcast
As the Official Healthcare Provider of the 2024 NASCAR Chicago Street Race, we’re thrilled to support such a memorable experience with this amazing community.
The innovative new treatment targets and destroys tumors using sound beams, noninvasively and without the need for needles and incisions.
A summary of the article goes here. A summary of the article goes here. A summary of the article goes here. A summary of the article goes here.
The innovative new treatment targets and destroys tumors using sound beams, noninvasively and without the need for needles and incisions.
Dr. Corbin on the gut microbiome research study
A genetic test, originally conducted to help better understand her daughter's diagnosis, revealed Samantha Arceneaux carries a genetic variant that virtually guarantees she will develop an aggressive...
Under the leadership of investigator Guru Sonpavde, MD, AdventHealth’s Clinical Research Unit (CRU), a collaborative between the AdventHealth Cancer Institute and AdventHealth Research Institute, is...
The AdventHealth Research Institute recently launched two new clinical studies to better understand and address the needs of healthcare employees who work night shifts.
In January 2024, AdventHealth Celebration neurotologist Michael Seidman, MD, FACS, became the first in Florida and the Southeast to complete a robotics-assisted cochlear implant procedure using the...
The CheckMate 901 Phase III clinical trial results, recently published in the New England Journal of Medicine, found that combining the programmed death 1 (PD1) inhibitor immunotherapy nivolumab with...